Episode
E271 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
- Podcast
- NEI Podcast
- Published
- Dec 17, 2025
- Duration seconds
- 2673
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nei-podcast-385769/episodes/e271-a-look-back-at-this-year-in-psychopharmacology-with-dr-roger-mcintyre/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nei-podcast-385769/e271-a-look-back-at-this-year-in-psychopharmacology-with-dr-roger-mcintyre.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry. Roger McIntyre , MD , FRCPC, is a globally recognized psychiatrist and psychopharmacologist who holds pivotal roles in academia, research, and leadership. His research primarily focuses on the phenomenology , neurobiology, and development of novel therapeutics for mood disorders. Dr. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto. Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York . Resources Thanarajah ES et al. Soft drink consumption and depression mediated by gut microbiome alterations . JAMA Psychiatry 2025;82(11):1095 – 1102. doi : 10.1001/jamapsychiatry.2025.2579 Durgam S et al. Lumateperone as adjunctive therapy in patients with major depressive disorder: results from a randomized, double-blind, phase 3 trial . J Clin Psychiatry 2025;86(4): 25m15848. doi : 10.4088/JCP.25m15848 Hendershot CS et al. Once- weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial . JAMA Psychiatry 2025;82(4):395 – 405. doi : 10.1001 / jamapsychiatry.2024.4789 Aron L et al. Lithium deficiency and the onset of Alzheimer's disease . Nature 2025;645:712 – 21. doi : 10.1038/s41586 - 025-09335-x Never miss an episode! 🎙 SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: ht…